---
title: "Canine TMPRSS4 in MDCK sublines enables trypsin-independent influenza A virus replication"
id: "biorxiv-2-endogenous-serine-proteases-in-mdck-sublines-support-trypsin-independent"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-2-endogenous-serine-proteases-in-mdck-sublines-support-trypsin-independent"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1?rss=1"
published_at: "2026-11-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Canine TMPRSS4 in MDCK sublines enables trypsin-independent influenza A virus replication
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-2-endogenous-serine-proteases-in-mdck-sublines-support-trypsin-independent
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1?rss=1)
- **Published At:** 2026-11-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study examined multiple Madin-Darby canine kidney (**MDCK**) sublines for their ability to support multicycle replication of **influenza A virus** without added trypsin. - MDCK-NBL2, MDCK-I, and MDCK-II sublines permitted trypsin-independent replication of human, porcine and avian IAV strains; other sublines did not. - Treatment with serine protease inhibitors camostat and nafamostat mesylate reduced viral replication in a dose-dependent fashion, according to the authors. - The inhibitors became less effective at higher viral inocula, a pattern the authors attributed to competitive interactions between HA and the inhibitors for protease binding. - Endogenous expression of several transmembrane serine proteases was detected across MDCK sublines; the authors specifically identified canine **TMPRSS2** and **TMPRSS4** among others. - Cellular localization differed: canine **TMPRSS4** localized mainly to the plasma membrane, while **TMPRSS2** did not show the same plasma membrane enrichment, investigators reported. - Functional assays indicated canine **TMPRSS4** activated HA more effectively than **TMPRSS2**, though activation efficiency varied by viral strain. - The authors concluded that certain MDCK sublines express functional HA-activating proteases, offering cell models for trypsin-independent IAV growth and for evaluating antivirals that target transmembrane serine proteases. - The manuscript is a preprint and has not undergone peer review; specific experimental parameters such as exact inhibitor concentrations, multiplicities of infection, and detailed assay conditions were not reported in the source abstract and should be consulted in the full text for replication.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=uzTLsbs7Zx0O.amc9wdDbYi9SQuYA4o3Q2LnJTGGzeg-1794948938.3223476-1.2.1.1-w4eQfkb3kXsfoHX8Oa8oDOPUBrkhpQ3fMi2S2MeiBu9oS0HhlGDf.wfSEGhNeY8x) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication Emma Balibrea Roelans, JIa-Yi Chan, Lisa Butticaz, Etori Aguiar Moreira, [ View ORCID Profile](http://orcid.org/0000-0002-2708-2507)Gert Zimmer doi: https://doi.org/10.64898/2026.11.16.766931 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Emma Balibrea Roelans 1 Institute of Virology and Immunology IVI, Switzerland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emma%2BBalibrea%2BRoelans%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Balibrea%20Roelans%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AEmma%2BBalibrea%2BRoelans%2B) JIa-Yi Chan 1 Institute of Virology and Immunology IVI, Switzerland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=JIa-Yi%2BChan%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Chan%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJIa-Yi%2BChan%2B) Lisa Butticaz 1 Institute of Virology and Immunology IVI, Switzerland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lisa%2BButticaz%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Butticaz%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALisa%2BButticaz%2B) Etori Aguiar Moreira 1 Institute of Virology and Immunology IVI, Switzerland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Etori%2BAguiar%2BMoreira%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Aguiar%20Moreira%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AEtori%2BAguiar%2BMoreira%2B) Gert Zimmer 2 Institute of Virology and Immunology, Switzerland * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gert%2BZimmer%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zimmer%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AGert%2BZimmer%2B) * [ORCID record for Gert Zimmer](http://orcid.org/0000-0002-2708-2507 "Open in new tab") * For correspondence: gert.zimmer@ivi.admin.ch * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5970812/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5970812/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5970812/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5970812/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The haemagglutinin (HA) of influenza A viruses (IAV) must be proteolytically cleaved by trypsin-like proteases to mediate fusion between the viral envelope and endosomal membrane of the host cell, a crucial step in virus entry. Most established cell lines rely on exogenous trypsin for the multicycle replication of influenza A viruses. In this study, we investigated various sublines of Madin-Darby canine kidney (MDCK) cells and found that MDCK-NBL2, MDCK-I, and MDCK-II support trypsin-independent replication of various influenza A viruses, including human, porcine, and avian strains. The serine protease inhibitors camostat and nafamostat mesylate reduced viral replication in a dose-dependent manner. However, the inhibitory effect diminished with increasing viral dose, most likely due to competition between the HA and the inhibitors for binding on the protease. We detected the endogenous expression of several transmembrane serine proteases in MDCK sublines, including TMPRSS2 and TMPRSS4. The characterization of these two canine serine proteases showed that TMPRSS4, but not TMPRSS2, is mainly localizing to the plasma membrane. Furthermore, canine TMPRSS4 was more effective than TMPRSS2 in terms of proteolytic activation of various influenza viruses, although there were strain-dependent differences. These results indicate that certain MDCK sublines express functional HA-activating proteases, providing useful models for the replication of influenza viruses without exogenous trypsin, as well as for the evaluation of antiviral strategies targeting transmembrane serine proteases. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.15.766795v1 "A harmonized functional reference framework for GBA1") Posted November 17, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.16.766931v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/17/2026.11.16.766931.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication Emma Balibrea Roelans, JIa-Yi Chan, Lisa Butticaz, Etori Aguiar Moreira, Gert Zimmer bioRxiv 2026.11.16.766931; doi: https://doi.org/10.64898/2026.11.16.766931 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.766931v1%26text%3DEndogenous%2520serine%2520proteases%2520in%2520MDCK%2520sublines%2520support%2520trypsin-independent%2520influenza%2520A%2520virus%2520replication "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.766931v1%26t%3DEndogenous%2520serine%2520proteases%2520in%2520MDCK%2520sublines%2520support%2520trypsin-independent%2520influenza%2520A%2520virus%2520replication "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.766931v1%26title%3DEndogenous%2520serine%2520proteases%2520in%2520MDCK%2520sublines%2520support%2520trypsin-independent%2520influenza%2520A%2520virus%2520replication%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.766931v1%26title%3DEndogenous%2520serine%2520proteases%2520in%2520MDCK%2520sublines%2520support%2520trypsin-independent%2520influenza%2520A%2520virus%2520replication "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.16.766931) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.16.766931v1&count=horizontal&via=&text=Endogenous%20serine%20proteases%20in%20MDCK%20sublines%20support%20trypsin-independent%20influenza%20A%20virus%20replication&counturl=www.biorxiv.org/content/10.64898/2026.11.16.766931v1 "Tweet This") ## Subject Area * [Microbiology ](https://www.biorxiv.org/collection/microbiology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46057) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20331) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27616) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14286) * [Ecology](https://www.biorxiv.org/collection/ecology) (21620) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26035) * [Genetics](https://www.biorxiv.org/collection/genetics) (16479) * [Genomics](https://www.biorxiv.org/collection/genomics) (24080) * [Immunology](https://www.biorxiv.org/collection/immunology) (19260) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (43684) * [Molecular Biology](https://www.biorxiv.org/collection/molecul
## Related Clinical Research

- [Optimizing AIV RNA Recovery from 40‑mL Water Samples: AC/PEG vs EM](https://medichelpline.com/clinical-feed/biorxiv-1-optimizing-avian-influenza-viral-rna-enrichment-from-water-a-comparison-of.md)
- [ReFRAME High-Throughput Screen Finds Repurposing Hits Active Against Toxoplasma gondii Tachyzoites](https://medichelpline.com/clinical-feed/biorxiv-0-high-throughput-screen-of-advanced-repurposing-library-identifies-compounds.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [Influenza and Coronavirus: Comparative Evolution, Epidemiology, Antivirals, and Vaccines](https://medichelpline.com/clinical-feed/pubmed-43058094.md) (DOI: 10.1038/s41392-026-03078-5)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.